Wang, Jun
li, Huawei
Xu, Ran
Lu, Tong
Zhao, Jiaying
Zhang, Pengfei
Qu, Lidong
Zhang, Shengqiang
Guo, Jida
Zhang, Linyou
Article History
Received: 22 December 2021
Accepted: 21 March 2022
First Online: 25 March 2022
Declarations
:
: For this study, the IRB(the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University) approved our application for waiver of informed consent.Because of our IRB(the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University) regulations, informed consent can be exempted as long as all the following conditions are met: The risk to the subjects in this study is not greater than the minimum risk. (Minimum risk refers to the possibility and degree of the expected risk in the research is not greater than the risk of daily life, or routine physical examination or psychological test.). Exemption of informed consent will not adversely affect the rights and health of subjects. Note: The patient only needs to accept the normal diagnosis and treatment process of the disease, and any medical treatment and rights will not be affected. The subjects' privacy and personally identifiable information are protected. Note: The personal information of patients in the study is confidential. Information that can identify patients will not be disclosed to members other than the research team. All study members and study sponsors are required to keep patient identities confidential. The patient file will only be available to researchers. In order to ensure that the research is carried out in accordance with regulations, when necessary, the government management department or the members of the ethics committee can review the patient data in the research unit according to the regulations. When the results of this research are published, no personal information about the patients will be disclosed. If informed consent is required, the research will not be possible (patients have the right to know that their medical records/specimen may be used for research, and their refusal or disagreement to participate in the research is not the reason why the research cannot be implemented or the informed consent is exempted). Note: Patients have the right to know that their tissue samples may be used for research and have the right to refuse to participate in the research. This study does not use medical records and specimens that patients/subjects have specifically refused to use in the past. Research using human body materials or data with identifiable information has failed to find the subject, and the research project does not involve personal privacy or commercial interests. We believe that our research meets the above conditions.
: This study was approved by the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University, Ethics number:KY2021-264 Because the study was retrospective, informed consent from patients was not needed. Patient data confidentiality rules are consistent with the Declaration of Helsinki.
: This study is a retrospective study, and the ethics committee's exemption consent application has been passed, and the relevant data is only used in this study.
: The authors declare that they have no competing interests.